|
US5200313A
(en)
|
1983-08-05 |
1993-04-06 |
Miles Inc. |
Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
|
|
US4777245A
(en)
|
1984-01-06 |
1988-10-11 |
Genelabs Incorporated |
Non-human primate monoclonal antibodies and methods
|
|
US4921698A
(en)
|
1984-05-25 |
1990-05-01 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5073492A
(en)
|
1987-01-09 |
1991-12-17 |
The Johns Hopkins University |
Synergistic composition for endothelial cell growth
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・2・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
NZ235148A
(en)
*
|
1989-09-05 |
1991-12-23 |
Immunex Corp |
Tumour necrosis factor receptor protein and dna sequences
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5744500A
(en)
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
AT396939B
(de)
|
1990-05-29 |
1993-12-27 |
Alois Dipl Ing Dr Jungbauer |
Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
|
|
AU652997B2
(en)
|
1991-01-21 |
1994-09-15 |
Elan Pharmaceuticals, Inc. |
Test and model for alzheimer's disease
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US6270766B1
(en)
*
|
1992-10-08 |
2001-08-07 |
The Kennedy Institute Of Rheumatology |
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
|
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
|
JPH07132033A
(ja)
|
1993-11-12 |
1995-05-23 |
Hoechst Japan Ltd |
アルツハイマー病モデルトランスジェニック動物
|
|
EP0679716A4
(en)
|
1993-11-12 |
1999-06-09 |
Kenichi Matsubara |
GENE SIGNATURE.
|
|
US20030198640A1
(en)
|
1994-11-07 |
2003-10-23 |
Human Genome Sciences, Inc. |
Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
|
|
US6544761B2
(en)
|
1994-12-13 |
2003-04-08 |
Human Genome Sciences, Inc. |
Human tissue inhibitor of metalloproteinase-4
|
|
ATE354638T1
(de)
|
1994-12-13 |
2007-03-15 |
Human Genome Sciences Inc |
Menschlicher gewebsinhibitor von metalloproteinase-4
|
|
EP0859841B1
(en)
|
1995-08-18 |
2002-06-19 |
MorphoSys AG |
Protein/(poly)peptide libraries
|
|
ATE239041T1
(de)
*
|
1996-02-09 |
2003-05-15 |
Basf Ag |
Humane antikörper welche an humanen tnfalpha binden
|
|
US7129061B1
(en)
*
|
1996-08-07 |
2006-10-31 |
Biogen Idec Ma Inc. |
Tumor necrosis factor related ligand
|
|
CA2262756C
(en)
|
1996-08-07 |
2012-06-12 |
Biogen, Inc. |
A tumor necrosis factor related ligand
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
US5858991A
(en)
|
1997-01-29 |
1999-01-12 |
Vanderbilt University |
Facilitation of wound healing with CM101/GBS toxin
|
|
JP2001513626A
(ja)
*
|
1997-02-12 |
2001-09-04 |
アボツト・ラボラトリーズ |
疾患の治療及び診断のために有用なtnfファミリーのメンバー
|
|
US7368531B2
(en)
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
PT1015477E
(pt)
|
1997-05-30 |
2010-12-28 |
Human Genome Sciences Inc |
32 proteínas humanas segregadas
|
|
US7001992B2
(en)
|
1997-05-30 |
2006-02-21 |
Human Genome Sciences, Inc. |
Antibodies to secreted protein HEMCM42
|
|
WO1998055508A2
(en)
|
1997-06-03 |
1998-12-10 |
Sagami Chemical Research Center |
HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
|
|
AU9376498A
(en)
|
1997-09-05 |
1999-03-22 |
University Of Washington |
Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
|
|
WO1999014330A1
(en)
|
1997-09-18 |
1999-03-25 |
Genentech, Inc. |
DcR3 POLYPEPTIDE, A TNFR HOMOLOG
|
|
AU749948B2
(en)
|
1997-10-10 |
2002-07-04 |
Genentech Inc. |
APO-3 ligand
|
|
US20020072089A1
(en)
|
1999-11-23 |
2002-06-13 |
Holtzman Douglas A. |
Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
|
|
US6046381A
(en)
|
1998-04-30 |
2000-04-04 |
The Regents Of The University Of California |
Apolipoprotein E transgenic mice and assay methods
|
|
WO1999059614A1
(en)
|
1998-05-20 |
1999-11-25 |
Yale University |
Modulation of angiogenesis and wound healing
|
|
EP1080194A2
(en)
|
1998-05-29 |
2001-03-07 |
Incyte Pharmaceuticals, Inc. |
Human transmembrane proteins
|
|
IL142539A0
(en)
|
1998-10-16 |
2002-03-10 |
Immunex Corp |
Inhibitors of platelet activation and recruitment
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
IL143031A0
(en)
|
1998-12-22 |
2002-04-21 |
Genentech Inc |
Methods and compositions for inhibiting neoplastic cell growth
|
|
EA004590B1
(ru)
*
|
1999-01-15 |
2004-06-24 |
Байоджен, Инк. |
Способ блокировки развития, или снижения тяжести, или проявлений заболевания "трасплантат против хозяина"
|
|
US20020004041A1
(en)
|
1999-02-19 |
2002-01-10 |
Albert Matthew L. |
Methods for abrogating a cellular immune response
|
|
PT1623990E
(pt)
|
1999-03-08 |
2008-03-18 |
Genentech Inc |
Composições e métodos para o tratamento de tumores
|
|
US6521424B2
(en)
|
1999-06-07 |
2003-02-18 |
Immunex Corporation |
Recombinant expression of Tek antagonists
|
|
KR20050004240A
(ko)
|
1999-08-31 |
2005-01-12 |
제넨테크, 인크. |
종양 치료용 조성물 및 방법
|
|
US7495086B2
(en)
|
1999-12-20 |
2009-02-24 |
Immunex Corporation |
TWEAK receptor
|
|
US6727225B2
(en)
|
1999-12-20 |
2004-04-27 |
Immunex Corporation |
TWEAK receptor
|
|
CA2394015C
(en)
*
|
1999-12-20 |
2013-11-05 |
Immunex Corporation |
Tweak receptor
|
|
EP1908780B1
(en)
|
2000-01-03 |
2012-08-15 |
The Trustees Of The University Of Pennsylvania |
Novel chimeric proteins and methods for using the same
|
|
US7927602B2
(en)
|
2002-07-23 |
2011-04-19 |
University Of Louisville Research Foundation, Inc. |
Fas ligand-avidin/streptavidin fusion proteins
|
|
AU2001233034A1
(en)
|
2000-01-27 |
2001-08-07 |
American Cyanamid Company |
Method for preparing alpha-sulfonyl hydroxamic acid derivatives
|
|
US7074408B2
(en)
|
2000-02-25 |
2006-07-11 |
Immunex Corporation |
Use of integrin antagonists to inhibit angiogenesis
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
US6943146B2
(en)
*
|
2000-05-08 |
2005-09-13 |
Biogen Idec Ma Inc. |
Method for promoting neovascularization
|
|
US7498304B2
(en)
|
2000-06-16 |
2009-03-03 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
|
US20040047854A1
(en)
|
2001-07-27 |
2004-03-11 |
Black Roy A. |
Human disintegrin protein
|
|
AU8901901A
(en)
|
2000-09-14 |
2002-03-26 |
Biogen Inc |
Tweak receptor agonists as anti-angiogenic agents background
|
|
US7208151B2
(en)
*
|
2001-09-12 |
2007-04-24 |
Biogen Idec Ma Inc. |
Tweak receptor agonists as anti-angiogenic agents
|
|
AU1305302A
(en)
|
2000-10-05 |
2002-04-15 |
Immunex Corp |
Nectin polypeptides, polynucleotides, methods of making and use thereof
|
|
EP1354950A4
(en)
|
2000-12-28 |
2005-01-12 |
Asahi Kasei Pharma Corp |
ACTIVATION GENE OF NF-KB
|
|
EP1423134A2
(en)
|
2001-03-21 |
2004-06-02 |
Human Genome Sciences |
Human secreted proteins
|
|
US20040203083A1
(en)
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
|
WO2002094864A2
(en)
|
2001-05-25 |
2002-11-28 |
Genset S.A. |
Human cdnas and proteins and uses thereof
|
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
|
WO2003040307A2
(en)
|
2001-07-27 |
2003-05-15 |
Human Genome Sciences, Inc. |
Heteromultimeric tnf ligand family members
|
|
US20040091473A1
(en)
|
2001-07-27 |
2004-05-13 |
Dubose Robert F. |
Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
|
|
US20030148314A1
(en)
|
2001-08-01 |
2003-08-07 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
|
|
US20040033495A1
(en)
|
2001-08-03 |
2004-02-19 |
Eos Biotechnology, Inc. |
Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
|
|
WO2003070763A1
(en)
|
2001-08-16 |
2003-08-28 |
Human Genome Sciences, Inc. |
Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
|
|
AU2003224950B2
(en)
*
|
2002-04-09 |
2006-09-14 |
Biogen Ma Inc. |
Methods for treating tweak-related conditions
|
|
US7754884B2
(en)
|
2005-01-03 |
2010-07-13 |
Vanderbilt University |
Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
|
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
AU2004205631A1
(en)
|
2003-01-16 |
2004-08-05 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
WO2004074433A2
(en)
|
2003-01-30 |
2004-09-02 |
Yale University |
Rag polypeptides, nucleic acids, and their use
|
|
WO2004074506A2
(en)
|
2003-02-13 |
2004-09-02 |
Mergen Ltd |
Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers
|
|
WO2004072266A2
(en)
|
2003-02-13 |
2004-08-26 |
Kalobios Inc. |
Antibody affinity engineering by serial epitope-guided complementarity replacement
|
|
WO2004079014A2
(en)
|
2003-03-04 |
2004-09-16 |
Arcturus Bioscience, Inc. |
Signatures of er status in breast cancer
|
|
JP4823060B2
(ja)
|
2003-07-24 |
2011-11-24 |
アムジェン インコーポレイテッド |
Tweak受容体のマルチマー化およびオリゴマー化可溶性断片に関する組成物および方法
|
|
EP1566636A1
(en)
|
2004-02-23 |
2005-08-24 |
AXARON Bioscience AG |
Use of Tweak modulators and inhibitors for the treatment of neurological conditions
|
|
EP1811838A4
(en)
|
2004-11-08 |
2009-07-22 |
Univ Maryland |
TWEAK AS A THERAPEUTIC TARGET FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM IN CONNECTION WITH CEREBRAL OEDEM AND CELL DEATH
|
|
US7939490B2
(en)
*
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
|
AU2006214179A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Biogen Idec Ma Inc. |
Treating neurological disorders
|
|
WO2006088890A2
(en)
|
2005-02-17 |
2006-08-24 |
Biogen Idec Ma Inc. |
Treating stroke
|
|
CN101171035A
(zh)
|
2005-03-07 |
2008-04-30 |
健泰科生物技术公司 |
用于调控tweak和fn14活性的方法和组合物
|
|
WO2006122187A2
(en)
|
2005-05-10 |
2006-11-16 |
Biogen Idec Ma Inc. |
Treating and evaluating inflammatory disorders
|
|
WO2006130374A2
(en)
*
|
2005-05-27 |
2006-12-07 |
Biogen Idec Ma Inc. |
Tweak binding antibodies
|
|
WO2006130429A2
(en)
|
2005-05-27 |
2006-12-07 |
Biogen Idec Ma Inc. |
Treatment of cancer
|
|
WO2006138219A2
(en)
|
2005-06-13 |
2006-12-28 |
Biogen Idec Ma Inc. |
Methods of diagnosis / prognosis of inflammatory conditions
|
|
WO2008048924A2
(en)
|
2006-10-16 |
2008-04-24 |
Biogen Idec Ma Inc. |
Biomarkers of multiple sclerosis
|
|
AU2009246640A1
(en)
|
2008-05-15 |
2009-11-19 |
Biogen Idec Ma Inc. |
Anti-Fn14 antibodies and uses thereof
|
|
WO2010085648A2
(en)
|
2009-01-23 |
2010-07-29 |
Linda Burkly C |
Methods for reducing radiation-induced tissue damage
|
|
MX2011007936A
(es)
|
2009-01-30 |
2011-08-17 |
Biogen Idec Inc |
Metodos para regeneracion de tejido pancreatico.
|
|
BR112013007293A2
(pt)
|
2010-10-05 |
2016-06-14 |
Hoffmann La Roche |
anticorpos contra a tweak de seres humanos e suas utilizações
|